![](/img/cover-not-exists.png)
Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial
Linz, P. E., Lovato, L. C., Byington, R. P., O'Connor, P. J., Leiter, L. A., Weiss, D., Force, R. W., Crouse, J. R., Ismail-Beigi, F., Simmons, D. L., Papademetriou, V., Ginsberg, H. N., Elam, M. B.Volume:
37
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/dc13-0790
Date:
March, 2014
File:
PDF, 819 KB
english, 2014